Clinical Trials Browser

OTHER × Lymphoma × epratuzumab × Clear all

NCT00301821 2019-10-09

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Phase 2 Completed

107 enrolled 8 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00553501 2016-07-06

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Phase 2 Completed

60 enrolled 7 charts

Lymphoma, Lymphoma, Follicular